NuVasive's GAAP loss for 2020 was $37.153 million, compared to a profit of $65.234 million in the previous year. Revenue declined 10% to $1.051 billion from $1.168 billion a year earlier.
NuVasive's GAAP loss for 2020 was $37.153 million, compared to a profit of $65.234 million in the previous year. Revenue declined 10% to $1.051 billion from $1.168 billion a year earlier. 
ir.nuvasive.com
English (US) 